Subacute demyelinating disease in an adult (diffuse-disseminated sclerosis).
D000324:Adrenocorticotropic Hormone / Q000008:administration & dosage; D000328:Adult; D002512:Cephalothin / Q000627:therapeutic use; D002701:Chloramphenicol / Q000627:therapeutic use; D003907:Dexamethasone / Q000008:administration & dosage; D005260:Female; D005839:Gentamicins / Q000627:therapeutic use; D006493:Heparin / Q000627:therapeutic use; D006801:Humans; D006854:Hydrocortisone / Q000627:therapeutic use; D007612:Kanamycin / Q000008:administration & dosage; D007668:Kidney / Q000473:pathology; D009103:Multiple Sclerosis / Q000134:cerebrospinal fluid / Q000150:complications / Q000188:drug therapy / Q000473:pathology; D011241:Prednisone / Q000008:administration & dosage; D011655:Pulmonary Embolism / Q000150:complications / Q000188:drug therapy; D013116:Spinal Cord / Q000473:pathology; D013752:Tetracycline / Q000627:therapeutic use; D014552:Urinary Tract Infections / Q000150:complications / Q000188:drug therapy
D005839:Gentamicins; D007612:Kanamycin; D002701:Chloramphenicol; D003907:Dexamethasone; D000324:Adrenocorticotropic Hormone; D006493:Heparin; D013752:Tetracycline; D002512:Cephalothin; D011241:Prednisone; D006854:Hydrocortisone